Please assess the completion status of the following clinical trial:

Trial Title: Impact of Vaccination on Th2 Immunity in Infancy

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Written informed consent from parent/guardian~* General good health without other known need for blood draws that would conflict with the study volume requirements~* Aged 5 months - 7 months, any race/ethnicity, any gender~* Subjects must not have yet received their third DTaP vaccination, which typically is given at 6 months of age. Subjects must have previously received two doses of the DTaP vaccination, at ages 2 months and 4 months~* Willingness to return for follow-up testing as defined in the protocol and consent if screening tests indicate eligibility~* Group 1 participants must have all of the following:~  * A negative skin prick test to egg, milk, and peanut~ * A negative IgE to egg, milk, and peanut~* Group 2 participants must have all of the following:~  * A positive family history of allergic disease~ * Atopic Dermatitis not requiring prescription medication~ * A positive IgE to milk, egg, and/or peanut~If Group 1 enrollment is completed first, participants must have all of the following to be enrolled in Group 2:~* A family history of atopy~* Atopic dermatitis not requiring prescription medication~If Group 2 enrollment is completed first, participants must have all of the following to be enrolled in Group 1:~-No personal or family history of atopic disease~Exclusion Criteria:~* History of anemia requiring any treatment~* Previous allergic reaction to any food, defined as itching, rash, hives, swelling, vomiting, diarrhea, sneezing, rhinorrhea, wheezing, breathing difficulty, or passing out immediately after food ingestion.~* Evidence of non-IgE-mediated reaction to milk or soy (i.e. milk/soy protein intolerance) or evidence of food protein induced enterocolitis syndrome (FPIES)~* Severe atopic dermatitis (liberally defined as requiring prescription medication)~* Unable to obtain serum sample for determination of egg, milk and peanut IgE levels~* Use of short-acting anti-histamines (diphenhydramine, etc.) more than one time within 3 days of skin testing or on the day of skin testing~* Any history of intravenous or oral steroid medication~* Known underlying immune defect/deficiency or bleeding disorder

- Gender: ALL
- Minimum Age: 5 Months
- Maximum Age: 7 Months
- Healthy Volunteers: t

Study Arms:
- Positive blood test to milk, egg, and/or peanut (Type: None): Family history to atopy
- Negative blood test to allergy (Type: None): A negative skin prick test to egg, milk, and peanut and a negative Immunoglobulin E (IgE) to egg, milk, and peanut.

Based on this trial design, predict the completion outcome and termination type (if applicable).